Espra L 75mg/40mg Capsule is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, designed to treat gastrointestinal disorders. Levosulpiride is a prokinetic agent that enhances gastrointestinal motility by blocking dopamine receptors, thereby improving symptoms such as nausea, vomiting, bloating, and abdominal discomfort often associated with functional dyspepsia and gastroesophageal reflux disease (GERD). Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in the stomach lining, providing relief from acid-related conditions like GERD, peptic ulcers, and erosive esophagitis. The combined action of these two active ingredients helps in alleviating symptoms related to acid reflux and impaired gastric motility, promoting faster healing of the esophageal lining and improving digestive comfort. Espra L is typically prescribed for patients experiencing persistent heartburn, acid regurgitation, and delayed gastric emptying. It should be taken as directed by a healthcare professional, usually before meals. Patients with known hypersensitivity to either component, severe liver or kidney impairment, or those pregnant or breastfeeding should consult their doctor before use. Common side effects may include headache, dizziness, or mild gastrointestinal disturbances.